|
|
Curriculum Vitae
Name: Andreas Sputtek
Academic title: Dr. med.
Education: 1974-1979 Study of and intermediate diploma in Chemistry, Ruhr-University Bochum, Germany; 1979-1985 Study of Human Medicine, RWTH Aachen University, Germany
Qualifications: i) Board certified «laboratory medicine» 11/2016; ii) Board certified «transfusion medicine» 04/2000; iv) «JACIE Inspector» 06/2008; http://www.jacie.org/; authorization for further training in laboratory medicine 06/2021
Appointments:
Since 2017 Medical Labratory Bremen, Bremen, Germany, Authorized Officer
2015-2016 Center for Laboratory Medicine and Microbiology, Essen, Germany, Chief Resident
2013-2014 Limbach Laboratories Neumuenster, Neumuenster, Germany, Medical Director
1994-2012 Institute of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Head hematopoietic stem cell processing (01/1996 - 12/2012), ii) Qualified Person («Sachkundige Person §14 AMG», 06/2012 - 12/2012), iii) Head quality control laboratory (01/1994 - 12/2012), iv) Head red cell compatibility testing laboratory (05/2009-10/2011).
1985-1993 Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Germany; Research Assistant/Fellow
Awards: i) «Wilhelm Borchers Plakette» for summa cum laude MD thesis defense, 1990 ii) «Friedrich Wilhelm Preis» for outstanding scientific dissertation thesis, 1991
Scientific societies:
i) Society for Cryobiology (SFC), Bethesda, MD, USA, since 1991; Treasurer, 1996-1997; Governor, 1998-2003; President-Elect, 2004-2005; President, 2006-2007; Past President, 2008-2009; Secretary, 2010-2011; Governor, 2012-2014; http://www.societyforcryobiology.org
ii) Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), since 1991; Editorial Office "Transfusion Medicine and Hemotherapy", 1997-2005; http://www.dgti.de
iii) Society for Low Temperature Biology (SLTB), London, UK, since 1994; Committee Member, 1996-2002; Meetings Secretary, 1999-2002; Chairman, 2002-2005; http://www.sltb.info
iv) Institute International du Froid (IIR), Paris, France, since 1996; Working Member Commission C1 (Freeze-drying, Cryobiology, Medical Applications), since 2002; http://www.iifiir.org
v) American Association of Blood Banks (AABB), 1996-2007; http://www.aabb.org
vi) European Association of Tissue Banks (EATB), 1996-2007; http://www.eatb.de
vii) International Society for Cellular Therapy (ISCT), 1998-2007; http://www.celltherapy.org
Editorial boards:
i) Cryobiology, since 1996; http://www.elsevier.com/locate/cryo
ii) CryoLetters, 2001-2004; since 2007; http://www.cryoletters.org
iii) Biopreservation and Biobanking, 2002-2015; http://www.liebertpub.com/editorialboard/biop reservation-and-biobanking-formerly-cell-pres ervation-technology/110/
iv) Transfusion Medicine and Hemotherapy, 2006-2020; http://www.karger.com/tmh
Meetings:
i) Member Local Organizing Committee: CRYO 1988, 25th Annual Meeting Society for Cryobiology, Aachen
ii) Local Organizer & Conference Chair: 1997 Spring Meeting Society for Low Temperature Biology, Hamburg (sponsored by German Science Foundation, DFG)
iii) Local Organizer & Conference Chair: CRYO 2006, 43rd Annual Meeting Society for Cryobiology, Hamburg (sponsored by German Science Foundation, DFG); http://www.sputtek.de/app/download/5788784460 /CRYO2006_ProgramAbstracts.pdf
Government funded research projects:
i) Federal Ministry of Defense (BMVg): Blood replacement by cryopreserved red blood cell concentrates: effect on blood and plasma rheology, microcirculation and tissue oxygenation, 1988-1993
ii) Federal Ministry of Education and Research (BMBF): Replacement of a pyrogen test in rabbits by an in vitro whole blood test, 2000-2003
iii) Federal Ministry of Education and Research (BMBF): Established immunotolerance in MS patients (ETIMS), 2010
Scientific interest:
i) Physico-chemical properties and mechanisms of action of cryoprotectants, especially non-penetrating carbohydrates; development and improvement of cryopreservation techniques for a variety of blood cells (peripheral blood stem cell progenitors, erythrocytes, thrombocytes, lymphocytes and monocytes) for therapeutic and diagnostic purposes.
ii) Bioartificial liver replacement using cryopreserved hepatocytes
iii) Peptide-coupled peripheral blood mononuclear cells for induction of immunotolerance in multiple sclerosis patients
iv) Effect of CD133 positive autologous bone marrow derived stem cells for improving left ventricular function
Publications: 74 scientific papers in journals and book chapters (35 PubMed listed, 36 first author), 135 abstracts in peer reviewed journals, 2 international patents
August 25, 2021
(c) Andreas Sputtek
|
|
5x
|
|
Bitte einen Moment...